Purdue Pharma Cuts More Than Half of U.S. Sales Staff Amid Opioid Crisis Post author:Sam Post published:February 12, 2018 Post category:BioPharma That announcement is a big change in the way Purdue has aggressively marketed OxyContin in the past. Source: BioSpace You Might Also Like San Diego's Arena Soars as Phase II Hypertension Trial Data Wows July 10, 2017 Rumor Alert: Sanofi Close to Scooping Up This Massachusetts Biotech in $1 Billion+ Deal March 22, 2017 Lupin Coughs Up $150 Million Cash for This New Jersey-Based Biopharma October 10, 2017
Rumor Alert: Sanofi Close to Scooping Up This Massachusetts Biotech in $1 Billion+ Deal March 22, 2017